Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B

Aliment Pharmacol Ther. 2021 Mar;53(6):761-762. doi: 10.1111/apt.16264.

Authors

Rui Huang¹, Jiacheng Liu², Jian Wang¹, Xiaomin Yan¹, Chao Wu¹

Affiliations

¹ Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
² Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

PMID: 33599329
DOI: 10.1111/apt.16264

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular* / epidemiology
DNA
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis B virus / genetics
Hepatitis B, Chronic* / complications
Hepatitis B, Chronic* / epidemiology
Humans
Liver Neoplasms* / epidemiology

Substances

Hepatitis B Surface Antigens
Hepatitis B e Antigens
DNA